SEC 13F Intelligence

Canaan Partners X LLC / IDYA

Canaan Partners X LLC’s Ideaya Biosciences Inc Position

Does Canaan Partners X LLC own Ideaya Biosciences Inc (IDYA)? Yes2.66M shares worth $72M (+96.06% of its 13F portfolio) as of Q3 2023.

Position Value
$72M
Q3 2023
Shares
2.66M
% of Portfolio
+96.06%
Quarters Held
16
currently held

Position History IDYA

Reported value by quarter
Q4 ’19: $20MQ4 ’19Q1 ’20: $11MQ2 ’20: $38MQ2 ’20Q3 ’20: $33MQ4 ’20: $37MQ4 ’20Q1 ’21: $63MQ2 ’21: $56MQ2 ’21Q3 ’21: $68MQ4 ’21: $63MQ4 ’21Q1 ’22: $30MQ2 ’22: $37MQ2 ’22Q3 ’22: $40MQ4 ’22: $48MQ4 ’22Q1 ’23: $37MQ2 ’23: $63MQ2 ’23Q3 ’23: $72Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 20232.66M$72M+96.06%
Q2 20232.66M$63M+74.33%
Q1 20232.66M$37M+65.16%
Q4 20222.66M$48M+84.97%
Q3 20222.66M$40M+62.26%
Q2 20222.66M$37M+63.52%
Q1 20222.66M$30M+30.23%
Q4 20212.66M$63M+24.52%
Q3 20212.66M$68M+19.31%
Q2 20212.66M$56M+83.88%
Q1 20212.66M$63M+85.23%
Q4 20202.66M$37M+77.44%
Q3 20202.66M$33M+66.44%
Q2 20202.66M$38M+45.36%
Q1 20202.66M$11M+12.07%
Q4 20192.66M$20M+12.90%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Canaan Partners X LLC’s full portfolio or all institutional holders of IDYA.